The chromogranins and the counter-regulatory hormones: do they make homeostatic sense?
- PMID: 10358106
- PMCID: PMC2269385
- DOI: 10.1111/j.1469-7793.1999.0643s.x
The chromogranins and the counter-regulatory hormones: do they make homeostatic sense?
Abstract
1. The chromogranins are ubiquitous proteins which are co-stored and co-secreted with many peptide hormones. All appear to be powerful inhibitors of endocrine secretions. This poses a problem. 2. When endocrine glands are involved in the efferent limbs of homeostatic loops, they are message transmitters. The self-inhibition caused by the co-secretion of a chromogranin will, on the face of it, erase the message. 3. Pairs of counter-regulatory homeostatic hormones also present a problem. 4. If both members of the pair have clearly defined set points, as suggested by their 'time integral' (or 'growth with time') responsiveness to deviations from set point, then, if the two set points are not exactly the same, one or other member will always register an error, leading, eventually, to an overwhelmingly large and unnecessary response. 5. Our model eliminates both paradoxes, and emphasizes the importance of counter-regulation and the co-secretion of chromogranins in 'zero steady-state error' (ZSSE) homeostasis. 6. If hormone A is secreted into the blood in progressively increasing amounts when [Q], the plasma concentration of substance Q, is low, and in decreasing amounts when [Q] is high; and hormone B responds in the opposite manner, then there will be a [Q], designated [Q]p, at which the secretory rate increase, or decrease, of the two hormones is exactly the same. 7. If, in addition, the secretion of both hormones is stimulated by low plasma chromogranin levels, [Cg], but inhibited by high [Cg] then there will be a different [Q]p for every chromogranin concentration in the blood. 8. At one of these points (at a unique [Q] and [Cg]) the concentration of neither hormone will increase or decrease. This is the equilibrium point to which, according to our model, the system always returns regardless of disturbances within physiological limits. 9. This is robust ZSSE control.
Figures


Similar articles
-
Widespread occurrence of chromogranins/secretogranins in the matrix of secretory granules of endocrinologically silent pituitary adenomas.J Histochem Cytochem. 1992 Apr;40(4):523-33. doi: 10.1177/40.4.1552186. J Histochem Cytochem. 1992. PMID: 1552186
-
Current status on chromogranin A and pancreastatin.Acta Gastroenterol Belg. 1993 May-Aug;56(3-4):261-3. Acta Gastroenterol Belg. 1993. PMID: 8266767 Review.
-
New suggestions for the physiological role of secretory protein-I.Bone Miner. 1987 Jul;2(4):251-5. Bone Miner. 1987. PMID: 3333318 Review.
-
Neuropeptides and chromogranins: session overview.Ann N Y Acad Sci. 2002 Oct;971:294-9. doi: 10.1111/j.1749-6632.2002.tb04483.x. Ann N Y Acad Sci. 2002. PMID: 12438139 Review.
-
Autocrine regulation of parathyroid secretion: inhibition of secretion by chromogranin-A (secretory protein-I) and potentiation of secretion by chromogranin-A and pancreastatin antibodies.Endocrinology. 1990 Sep;127(3):1329-35. doi: 10.1210/endo-127-3-1329. Endocrinology. 1990. PMID: 2387256
Cited by
-
Robust perfect adaptation in bacterial chemotaxis through integral feedback control.Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4649-53. doi: 10.1073/pnas.97.9.4649. Proc Natl Acad Sci U S A. 2000. PMID: 10781070 Free PMC article.
-
Complex systems model of fatigue: integrative homoeostatic control of peripheral physiological systems during exercise in humans.Br J Sports Med. 2005 Jan;39(1):52-62. doi: 10.1136/bjsm.2003.011247. Br J Sports Med. 2005. PMID: 15618343 Free PMC article. Review.
-
A reappraisal of the blood glucose homeostat which comprehensively explains the type 2 diabetes mellitus-syndrome X complex.J Physiol. 2003 Jun 1;549(Pt 2):333-46. doi: 10.1113/jphysiol.2002.037895. Epub 2003 Apr 25. J Physiol. 2003. PMID: 12717005 Free PMC article. Review.
-
Immunohistochemical evaluation of the post-translational processing of chromogranin A in human pituitary adenomas.Pituitary. 2000 Oct;3(2):67-75. doi: 10.1023/a:1009949623054. Pituitary. 2000. PMID: 11141698 Clinical Trial.
-
Two chromogranin a-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2.PLoS One. 2009;4(2):e4501. doi: 10.1371/journal.pone.0004501. Epub 2009 Feb 19. PLoS One. 2009. PMID: 19225567 Free PMC article.
References
-
- Blaschko E, Comline RS, Schneider FH, Silver M, Smith AD. Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature. 1967;215:58–59. - PubMed
-
- Clynes M. Cybernetic implications of rein control in perceptual and conceptual organization. Annals of the New York Academy of Sciences. 1969;156:629–690. - PubMed
-
- Cohn DV, Elting J. Biosynthesis, processing, and secretion of parathormone and secretory protein-I. Recent Progress in Hormone Research. 1983;39:181–209. - PubMed
-
- Cohn DV, Elting JJ, Frick M, Elde R. Selective localization of the parathyroid secretory protein I/adrenal medulla chromogranin A protein family in a wide variety of endocrine cells of the rat. Endocrinology. 1984;114:1963–1974. - PubMed
-
- Cohn DV, Fasciotto BH, Reese BK, Zhang JX. Chromogranin A: a novel regulator of parathyroid gland secretion. Journal of Nutrition. 1995;125:2015–2019S. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical